Skip to main content
Clinical Trials/NCT02274298
NCT02274298
Unknown
Not Applicable

Improving Care for Patients With Chronic Kidney Disease Using Electronic Medical Record Interventions: A Pragmatic Cluster Randomized Trial

Sunnybrook Health Sciences Centre0 sites221 target enrollmentOctober 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Kidney Disease
Sponsor
Sunnybrook Health Sciences Centre
Enrollment
221
Primary Endpoint
Proportion of patients age 50-80 with Stage 3+ CKD and a statin prescription
Last Updated
9 years ago

Overview

Brief Summary

This pragmatic cluster randomized controlled trial will test the impact of feedback and a toolkit aimed at improving the management of chronic kidney disease (CKD) in the primary care setting. This trial will use family physicians in Ontario participating in the Electronic.

Detailed Description

This trial will use family physicians in Ontario participating in the Electronic Medical Record Administrative data Linked Database (EMRALD) and receiving the System for Audit and Feedback to Improve caRE (SAFIRE) along with other decision support tools. Performance on CKD quality indicators for family physicians receiving the CKD feedback and tools will be compared to physicians not receiving the CKD feedback or tools.

Registry
clinicaltrials.gov
Start Date
October 2014
End Date
April 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Karen Tu

Senior Scientist

Sunnybrook Health Sciences Centre

Eligibility Criteria

Inclusion Criteria

  • Family physicians participating in EMRALD, on the EMR for \>=2 years, roster size \>=100 patients
  • Patient criteria, rostered and actively seeing an EMRALD physician, on the EMR for .=1 year

Exclusion Criteria

  • Updated data available at the time of study commencement

Outcomes

Primary Outcomes

Proportion of patients age 50-80 with Stage 3+ CKD and a statin prescription

Time Frame: 24 months

Comparison of proportion of patients age 50-80 years with Stage 3+ CKD (no dialysis or renal transplant) and receiving a statin prescription at baseline and at the end of the trial

Secondary Outcomes

  • Proportion of patients with an initial eGFR <60 and a f/u eGFR or an ACR(24 months)
  • Proportion of patients meeting eGFR criteria for CKD and documentation of CKD in the cumulative patient profile (CPP)(24 months)
  • Proportion of patients age less than 80 years and an eGFR<30 being seen by or with a referral to a Nephrologist(24 months)
  • Proportion of patients at high risk screened for CKD with an eGFR and/or ACR(24 months)
  • Proportion of patients with diabetes and albuminuria and on an ACE or ARB(24 months)
  • Proportion of patients with an ACR in the past 18 months and meeting bp targets(24 months)

Similar Trials